Literature DB >> 11073740

Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis.

J Lipman1, A Allworth, S C Wallis.   

Abstract

Nosocomial meningitis due to gram-negative organisms is a difficult clinical problem to manage because of both antibiotic resistance and poor penetration of many antimicrobials across the blood-brain barrier. Ciprofloxacin has potential in treating this condition when used in high doses. We investigated the plasma and cerebrospinal fluid (CSF) levels of ciprofloxacin in a patient with Pseudomonas aeruginosa meningitis who was treated with 400 mg of intravenous ciprofloxacin every 8 hours. Ciprofloxacin levels in plasma peaked at 10.29 mg/L without resulting in accumulation (8-hour trough levels, <1 mg/L), whereas the CSF level increased to 0.9 mg/L. This CSF level was confirmed to be similar 1 week later. After 1 week of therapy, during which there were no side effects attributable to ciprofloxacin, the organism was eradicated, and there was some clinical improvement. We recommend that 400 mg of intravenous ciprofloxacin every 8 hours be considered for treatment of difficult-to-treat gram-negative bacillary meningitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073740     DOI: 10.1086/317462

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

2.  Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections.

Authors:  Ravina Kullar; Judy N Chin; David J Edwards; Dennis Parker; William M Coplin; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

Review 3.  Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury.

Authors:  Jason K Karimy; Benjamin C Reeves; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2020-04-17       Impact factor: 6.902

Review 4.  Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?

Authors:  Nilesh Kumta; Jason A Roberts; Jeffrey Lipman; Menino Osbert Cotta
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

5.  Fluoroquinolones in the Treatment of Meningitis.

Authors:  Philippe Cottagnoud; Martin G. Täuber
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

6.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Ciprofloxacin-associated choreoathetosis in a haemodialysis patient.

Authors:  Ahad Abdalla; Shazrul Ramly; Peter Boers; Liam Casserly
Journal:  BMJ Case Rep       Date:  2013-04-18

Review 8.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

9.  Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study.

Authors:  Kevin Meesters; Reiner Mauel; Evelyn Dhont; Johan Vande Walle; Pauline De Bruyne
Journal:  BMC Infect Dis       Date:  2018-02-23       Impact factor: 3.090

10.  Successful Use of Ertapenem for the Treatment of Enterobacter cloacae Complex Infection of the Central Nervous System (CNS).

Authors:  Sunish Shah; Dayna McManus; Jeffrey E Topal
Journal:  Case Rep Infect Dis       Date:  2019-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.